Senior Accountant (Revenue & Accounting Operations)
VersapaySalary not specified
Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, HealthcareIndustries
Requirements
- Bachelor’s degree in Accounting, Finance, or related field; CPA strongly preferred
- 7-10+ years of progressive experience in accounting, with at least 5 years focused on revenue recognition; biotech/life sciences industry experience required
- In-depth knowledge of ASC 606 and experience with complex arrangements such as milestones and licensing
- Deep experience with gross-to-net modeling and reporting, and government pricing programs in a commercial-stage biotech or pharmaceutical company
- Proven ability to partner cross-functionally and communicate complex revenue topics to non-finance stakeholders
- Experience leading teams and scaling processes in a high-growth environment
- Exceptional analytical skills, attention to detail, and ability to meet tight deadlines in a fast-paced setting
Responsibilities
- Own the end-to-end revenue accounting process, ensuring compliance with ASC 606 and company policies
- Oversee the gross-to-net (GTN) reporting and accrual process, including reserves for rebates, chargebacks, copay programs, patient support, government pricing, distribution fees, and returns
- Develop and maintain GTN models to ensure accurate forecasting of net product revenue and clear visibility into key drivers
- Collaborate cross-functionally with Commercial, Market Access, Supply Chain, and FP&A to monitor channel and payer dynamics and integrate insights into forecasts and accruals
- Ensure compliance with government pricing and reporting requirements, including Medicaid, Medicare, 340B, VA, and other federal/state programs
- Lead monthly, quarterly, and annual revenue close activities, including GL reconciliations, journal entries, analyses, and financial statement footnote disclosures
- Partner with Legal and Commercial teams to review new and existing contracts and agreements, assessing impact on revenue recognition
- Serve as the primary point of contact for external auditors on revenue-related matters
- Drive continuous improvements by enhancing systems, processes, and automation to support growth and operational efficiency
- Stay current with evolving accounting standards, industry trends, and regulatory updates; recommend and implement policy and procedure updates as needed
Skills
ASC 606
Revenue Recognition
GTN Modeling
Government Pricing
Medicaid
Medicare
340B
GL Reconciliation
Journal Entries
Financial Close
Contract Review
External Audit
Process Automation
Orca Bio
Develops and commercializes cell therapies
About Orca Bio
Orca Bio operates in the biotechnology sector, specifically focusing on cell therapies that utilize the body's own cells to treat diseases. The company works to enhance these therapies, aiming to make them safer and more effective for patients. Orca Bio's products are primarily used by healthcare providers who administer these therapies to patients as part of their treatment plans. Unlike many competitors, Orca Bio emphasizes a strong team culture and values communication with stakeholders, keeping them informed about the company's progress and developments. The goal of Orca Bio is to improve patient outcomes through advanced cell therapies, addressing conditions that currently have limited treatment options.
Menlo Park, CaliforniaHeadquarters
2016Year Founded
$186.8MTotal Funding
SERIES_DCompany Stage
Biotechnology, HealthcareIndustries
51-200Employees
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Unlimited Paid Time Off
401(k) Retirement Plan
Parental Leave
Risks
Emerging competition from BlueRock Therapeutics in stem cell therapies.
Aspen Neuroscience's advancements in personalized stem cell therapies pose a threat.
Competitors' focus on iPSC-derived therapies may overshadow Orca Bio's offerings.
Differentiation
Orca Bio focuses on high-precision cell therapies for cancer and autoimmune diseases.
Their lead product, Orca-T, shows promising relapse-free survival rates in clinical trials.
Orca Bio's therapies aim to replace diseased blood and immune systems with healthy ones.
Upsides
Orca-T demonstrated 87% relapse-free survival in a Phase 1b/2 trial.
FDA's expedited approval pathways could accelerate Orca Bio's market entry.
Advancements in gene editing enhance the efficacy of Orca Bio's cell therapies.
Related Jobs
RemoteRemoteDirector, Technical Revenue & Assurance
Confluent$230,400 - $276,500/year
Full Time
Senior (5 to 8 years)
RemoteRevenue Accountant
Qualified.com$110,000 - $130,000/year
- Full Time
- Junior (1 to 2 years)
RemoteRevenue Accounting Manager
JerrySalary not specified
- Full Time
- Senior (5 to 8 years), Expert & Leadership (9+ years)
RemoteRevenue Accounting Manager
OverjetSalary not specified
- Full Time
- Senior (5 to 8 years), Expert & Leadership (9+ years)
RemoteSenior Revenue Accountant - United States
JumpCloudSalary not specified
- Full Time
- Senior (5 to 8 years), Expert & Leadership (9+ years)
RemoteAssociate Director, Revenue Operations
AxiosSalary not specified
- Full Time
- Senior (5 to 8 years), Expert & Leadership (9+ years)
RemoteRevenue Accounting Manager
JerrySalary not specified
- Full Time
- Senior (5 to 8 years), Expert & Leadership (9+ years)
RemoteDirector, Revenue Accounting
AnaplanSalary not specified
RemoteController, Revenue & Billing
ChainguardSalary not specified
- Full Time
- Expert & Leadership (9+ years)
RemoteIndustry Architect, Life Sciences
Snowflake$116,000 - $156,100/year
- Full Time
- Expert & Leadership (9+ years)